Micro Labs Limited emerges as a preeminent technology-driven healthcare entity, recognized for its cutting-edge Research and Development (R&D) and state-of-the-art automation-driven manufacturing facilities. The company consistently excels in international regulatory audits, reinforcing its commitment to quality. Our noteworthy achievements are fortified by a robust distribution network and groundbreaking research initiatives, positioning us as one of India's rapidly growing healthcare entities. Notably, we hold the 14th rank in prescriptions and the 19th position in sales, attesting to our formidable presence in the industry. Micro's extensive brand portfolio encompasses top-tier offerings in various medical specialties such as Cardiology, Diabetology, Anti-infectives, Ophthalmology, Pain management, Dermatology, Neurology, and more. Our impressive portfolio includes acclaimed brands like DOLO, Caripill, Amlong, Lubrex, Tripride and many more, widely acknowledged and extensively prescribed for their effectiveness in various therapeutic areas. Beyond our commercial success, Micro Labs Limited maintains a steadfast commitment to social responsibility, actively aspiring to be a model corporate citizen. This dedication manifests in our initiatives focused on Environmental Protection and Social Initiatives, with substantial contributions in the spheres of education and health. For further insights, we invite you to explore our website at www.microlabsltd.com. Caution Notice: Micro Labs adheres to a formalized recruitment process facilitated exclusively through its internal HR department. In the event that you encounter a suspicious job offer, we urge you to report it immediately. Please exercise caution and refrain from providing any personal information or making any payments. Genuine job seekers are advised to apply for current openings exclusively through the official Micro Labs website. You can communicate with us by writing to hrrecruit@microlabs.in
External link for Micro Labs Limited
No 31, Race Course Road
No 31
Bengaluru, Karnataka 560001, IN
Our AVP Digital marketing & E comm Ashish Ahlawat represented our vision for environmental sensitivity at IHW Council #Dubai during sustainability hour. He highlighted our efforts in making Dolo 650 the first plastic neutral pharma brand of India.
Ashish Ahlawat, AVP Digital Marketing and E-Commerce at Micro Labs Limited, graced the Sustainability Hour in Dubai! He highlighted Micro Labs' efforts of making Dolo 650 the first plastic neutral pharma brand of India. #SustainabilityHour #IHWSummit
Micro Labs Limited reposted this
It was mentally stimulating to discuss the buzz word of the year #GenAI and its impact in healthcare as whole. Shared my opinions and learned a lot from other panelist’s experiences.
Panel Discussion: Leveraging Gen AI & ML for Ensuring Equitable Access & Improving Healthcare Delivery. Moderator: ➢ Ida Rachel S M, Associate Director Digital Health, PwC India Panelists: ➢ Tanin Chakraborty (tc), Sr Director & Global DPO, Biocon Biologics ➢ Dr. Balakrishna Shetty, MD, Pro Chancellor, Prof of Radiology, Malla Reddy University & Chief, ISHA Diagnostics ➢ ALBERT PATRICK, IT Head, MVJ Medical College And Research Hospital ➢ Virupaksh A., Director IT, MS, Ramaiah Group ➢ Ashish Ahlawat, AVP Digital Marketing & E-Commerce, Micro Labs Limited AI-powered platforms for personalized treatments, ensuring every patient receives optimal care. ➛ How predictive analytics help improve patient outcomes by identifying health risks early. ➛ ML models used for streamlining hospital operations and enhancing staff efficiency. ➛ Addressing the digital divide through AI tools accessible to non-urban regions, promoting equitable healthcare delivery. ➛ Panelists stressed that collaborative efforts among tech innovators, healthcare providers, and policymakers are key to ensuring widespread adoption of these technologies. #EletsHIS #HealthcareInnovation #TransformingHealthcare
Microlabs is committed to support innovation particularly in the field of healthcare. By this association we are pledging to further our support and strengthen the overall ecosystem of healthcare innovation. Ashish Ahlawat Diya Surana Monali Shill Deepika Rallapalli Prahlad Katte SHWETA SAHU Akash Kulkarni Rajveera Singh Kachhawa Nawaj Hussain Ganeshan C
📢Exciting Announcement📢 We're delighted to announce that Micro Labs Limited has joined us as an Associate Partner for the 𝟏𝟒𝐭𝐡 𝐄𝐥𝐞𝐭𝐬 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧 𝐒𝐮𝐦𝐦𝐢𝐭 & 𝐀𝐰𝐚𝐫𝐝𝐬. 📅 Date: 24th October 2024 📍 Location: Radisson Blu-Atria, Bengaluru 👉 Express Interest: https://lnkd.in/gD_kwqT Ashish Ahlawat #EletsHIS #HealthcareInnovation #TransformingHealthcare
🌟Micro Labs Fillings Update 🌟 Micro Labs has successfully received the 2nd CADIFA certification for Mirabegron API! Mirabegron is used to treat overactive bladder (OAB) by relaxing bladder muscles, reducing urgency and frequency. It's also used for neurogenic detrusor overactivity. We are delighted to share this news with you. Explore our range of APIs for Urology and beyond! Connect with us for collaborations or inquiries. #Mirabegron #CADIFA #CADIFAApproved #ANVISA #MicroLabs #API #MicroLabsAPI #APIPortfolio #ActivePharmaceuticalIngredients #Pharma #Brazil #LatinAmerica #LATAM #Urology #OveractiveBladder #Regulatory #Update
Innovation is something we are dedicated to discuss and implement. Watch our AVP Digital Marketing & Ecomm Ashish Ahlawat share his thoughts on #GenAI at Elets Technomedia Innovation summit Bangalore.
We are excited to announce that Ashish Ahlawat, AVP Digital Marketing & E-Commerce, Micro Labs Limited, will be joining us as a Speaker at the 14th Elets Healthcare Innovation Summit & Awards! 📅 Date: 24th October 2024 📍 Location: Radisson Blu-Atria, Bengaluru 👉 Express Interest: https://lnkd.in/gD_kwqT #EletsHIS #HealthcareInnovation #TransformingHealthcare
Mavacamten: A Breakthrough for the Heart🫀 Mavacamten is the first and only approved drug worldwide to treat adult patients with Symptomatic Obstructive Hypertrophic Cardiomyopathy. -Available in strength of 2.5mg, 5mg, 10mg &15mg capsules. -Approved for use in Europe, Australia, Brazil, Canada, Great Britain, Macau, Singapore, South Korea & Switzerland. -Approved by FDA in April 2022 under REMS programs. Micro Labs would like to share some of our product highlights as below: ✅ We have developed FORM A; acceptable in all markets based on the patent scenario ✅ Particle size can be customized to meet your specifications Connect with us to know more! #MicroLabs #MicroLabsAPI #Mavacamten #HeartDisease #Cardiomyopathy #Pharma #ActivePharmaceuticalIngredient #ProductHighlights #APIHighlights #Breakthrough #BreakthroughAPI
Breaking the Silence on #MentalHealth #Psychiatricdisorders such as anxiety, depression, bipolar disorder, mania, OCD, schizophrenia, insomnia, and substance abuse affect millions worldwide. Unfortunately, many suffer in silence, often facing stigma and misunderstanding. At Synapse, we believe it’s time to take a stand. Our campaign, "Break the Silence and Spread Awareness," aims to educate and empower individuals to recognize these disorders as real and impactful. Together, we can foster an environment where mental health is prioritized, conversations are encouraged, and stigma is dismantled. #MentalHealthAwareness #BreakTheSilence #Synapse #EndStigma #MentalHealthMatters #microlabs #neurologicaldisorders Ganeshan C Nawaj Hussain
Micro Labs Limited reposted this
Pharma Leaders, Nation's Biggest & Prestigious Healthcare Leadership Brand with Two Decades of healthcare reporting & Honoring Innovative Entrepreneurs, Enterprises & Healthcare Leaders.
Micro Labs Limited Micro Labs USA, Inc. has made strong presence in the export markets. #MicrolabsLimited
🕊The world has lost an iconic leader whose vision, compassion, and integrity shaped industries and touched countless lives. 🌎✨Ratan Tata’s legacy goes beyond business—he inspired us all to lead with purpose and serve with heart. His influence will continue to guide and inspire for generations to come. 💐Rest in peace, Ratan Tata. Your legacy will forever inspire us. Tata Group Ratan Tata
✨CPHI Milan 2024 begins today!✨ The wait is over! We are excited to showcase our robust API portfolio at CPHI Milan 2024, where quality meets cutting-edge technology! Micro Labs offers: ✅Quality assured and reliable APIs ✅Innovative solutions ✅Experienced team Our APIs are crafted with precision, ensuring highest standards of safety, reliability and efficacy. We understand the complexities of pharmaceutical production and are here to support your success. Visit us at Meeting room #4G36 at Fiera Milano, Italy on 8-10th October 2024 to discuss how we can collaborate to drive your big project forward! Our team can't wait to meet you! Rekha Yadav Nagaraj Naik Manisha Gupta #CPHI #CPHIMilan2024 #Milan #PharmaceuticalIndustry #ActivePharmaceuticalIngredients #MicroLabsLimited #MicroLabsAPI #BusinessDevelopment #BusinessOpportunity #EventsandConferences #Events2024